World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
28323
World Ranking
15508
National Ranking
7818

Bruce W. Bode publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bruce W. Bode sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 327 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bruce W. Bode D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bruce W. Bode sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bruce W. Bode is affiliated with Emory University in the United States. Their research predominantly focuses on the field of Medicine, with a specialization in Endocrinology, Diabetes and Metabolism. They have contributed extensively to understanding diabetes and its related disorders through a range of clinical studies and research publications.

The scientist's main fields of study and research topics include:

  • Endocrinology, Diabetes and Metabolism
  • Surgery
  • Genetics
  • Cardiology and Cardiovascular Medicine
  • Physiology

  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Diabetes Treatment and Management
  • Diabetes and associated disorders
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Adipose Tissue and Metabolism
  • Heart Rate Variability and Autonomic Control

Bode's frequent publication venues highlight the focus of their work and include:

  • Diabetes
  • Diabetes Technology & Therapeutics
  • Diabetes Care
  • Diabetes Obesity and Metabolism
  • Journal of the Endocrine Society

Notable recent papers authored or co-authored by Bruce W. Bode include:

  • "Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States," 2020, Journal of Diabetes Science and Technology
  • "Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial," 2023, The Lancet
  • "Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes," 2020, JAMA
  • "American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus," 2021, Endocrine Practice
  • "Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes," 2021, Diabetes Care

Frequent co-authors in Bruce W. Bode's research include:

  • Trang T. Ly
  • Anders L. Carlson
  • Jennifer L. Sherr
  • Anuj Bhargava
  • Bruce A. Buckingham

Best Publications

  • Continuous glucose monitoring and intensive treatment of type 1 diabetes.

    Tamborlane Wv;Beck Rw;Bode Bw

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

    Alan Garber;Robert Henry;Robert Ratner;Pedro A Garcia-Hernandez

  • Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial

    Melanie J. Davies;Richard Bergenstal;Bruce Bode;Robert F. Kushner

  • Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

    Philip Raskin;Elsie Allen;Priscilla Hollander;Andrew Lewin

  • Exercise management in type 1 diabetes: a consensus statement.

    Michael C Riddell;Ian W Gallen;Carmel E Smart;Craig E Taplin

  • Threshold-based insulin-pump interruption for reduction of hypoglycemia

    Richard M. Bergenstal;David C. K Klonoff;Satish K. Garg;Bruce W. Bode

  • Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

    Richard M. Bergenstal;Satish Garg;Stuart A. Weinzimer;Bruce A. Buckingham

  • Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

    Satish K Garg;Stuart A Weinzimer;William V Tamborlane;Bruce A Buckingham

  • Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial.

    Nicole Sherry;William Hagopian;Johnny Ludvigsson;Sunil M Jain

  • Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.

    Simon Heller;John Buse;Miles Fisher;Satish Garg

  • Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use

    Todd M. Gross;Bruce W. Bode;Daniel Einhorn;David M. Kayne

  • Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

    R E Ratner;S C L Gough;Chantal Mathieu;S Del Prato

  • Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.

    Irl B Hirsch;Jill Abelseth;Bruce W Bode;Jerome S Fischer

  • Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

    Philip Raskin;Bruce W. Bode;Jennifer B. Marks;Irl B. Hirsch

  • Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry

    Jenise C. Wong;Nicole C. Foster;David M. Maahs;Dan Raghinaru

  • New Insulin Delivery Recommendations

    Anders H. Frid;Gillian Kreugel;Giorgio Grassi;Serge Halimi

  • REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

    Grazia Aleppo;Katrina J Ruedy;Tonya D Riddlesworth;Davida F Kruger

  • International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors

    Thomas Danne;Satish Garg;Anne L. Peters;John B. Buse

  • Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

    Stephen C L Gough;Bruce Bode;Vincent Woo;Helena W Rodbard

Frequent Co-Authors

Satish K. Garg
Satish K. Garg University of Colorado Anschutz Medical Campus
Irl B. Hirsch
Irl B. Hirsch University of Washington
Simon Heller
Simon Heller University of Sheffield
William V. Tamborlane
William V. Tamborlane Yale University
John B. Buse
John B. Buse University of North Carolina at Chapel Hill
George Howard
George Howard University of Alabama at Birmingham
Ralph B. D'Agostino
Ralph B. D'Agostino Wake Forest University
Leena Mykkänen
Leena Mykkänen The University of Texas Health Science Center at San Antonio
Timothy J. Aitman
Timothy J. Aitman University of Edinburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond traditional paths to becoming a doctor, the healthcare field in the USA offers a variety of online degrees that can lead to rewarding medical careers. These programs can offer greater flexibility, affordability, and accessibility for students who wish to build a career in health services or advance their current qualifications.

For those interested in the administrative side of medicine, pursuing a medical coding certification online can open doors to entry-level roles in hospitals, clinics, and insurance companies. Likewise, registered nurses looking to progress in their field may want to research the most affordable nurse practitioner programs to become licensed nurse practitioners entirely online.

If finding an affordable pathway is your priority, you may be curious about what is the cheapest online college for nursing?. These programs offer accessible routes to becoming a registered nurse. For those pursuing leadership, academic, or advanced clinical roles, there are also online phd nursing programs that build expertise and open up further career opportunities.

Exploring these alternative pathways can help you identify the best route to a fulfilling healthcare career that fits your goals and lifestyle.

Best Scientists Citing Bruce W. Bode

Trending Scientists

Recently Published Articles